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Abstract 
We present for the first time a comparative analysis of blood and organ system data from 
trials with rats fed three main commercialized genetically modified (GM) maize (NK 603, 
MON 810, MON 863), which are present in food and feed in the world. NK 603 has been 
modified to be tolerant to the broad spectrum herbicide Roundup and thus contains resi-
dues of this formulation. MON 810 and MON 863 are engineered to synthesize two differ-
ent Bt toxins used as insecticides. Approximately 60 different biochemical parameters were 
classified per organ and measured in serum and urine after 5 and 14 weeks of feeding. GM 
maize-fed rats were compared first to their respective isogenic or parental non-GM 
equivalent control groups. This was followed by comparison to six reference groups, which 
had consumed various other non-GM maize varieties. We applied nonparametric methods, 
including multiple pairwise comparisons with a False Discovery Rate approach. Principal 
Component Analysis allowed the investigation of scattering of different factors (sex, weeks 
of feeding, diet, dose and group). Our analysis clearly reveals for the 3 GMOs new side ef-
fects linked with GM maize consumption, which were sex- and often dose-dependent. Ef-
fects were mostly associated with the kidney and liver, the dietary detoxifying organs, al-
though different between the 3 GMOs. Other effects were also noticed in the heart, adrenal 
glands, spleen and haematopoietic system. We conclude that these data highlight signs of 
hepatorenal toxicity, possibly due to the new pesticides specific to each GM corn. In addi-
tion, unintended direct or indirect metabolic consequences of the genetic modification 
cannot be excluded.   
Key words: GMO, toxicity, GM corn, rat, NK 603, MON 810, MON 863 
1. Introduction 
There is a world-wide debate concerning the 
safety and regulatory approval process of genetically 
modified (GM) crops and foods [1, 2]. In order to sci-
entifically address this issue, it is necessary to have 
access to toxicological tests, preferably on mammals, 
performed over the longest time-scales involving de-
tailed blood and organ system analyses. Furthermore, 
these tests should, if possible, be in accordance with 
OECD guidelines. Unfortunately, this has been a 
challenge since usually these are regulatory tests 
performed confidentially by industry prior to com-
mercialization of their GM crops, pesticides, drugs or 
chemicals. As a result, it is more instructive to inves-
tigate the available data that allows comparisons of 
s e v e r a l  G M O s  c o n s u m p t i o n s  o n  h e a l t h  e f f e c t s .  T h i s  
will allow the most appropriate statistical analyses to Int. J. Biol. Sci. 2009, 5 
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be performed in order to avoid possible false positive 
as well as false negative results. The physiological 
criteria used to either accept or reject any GM signifi-
cant effect as relevant should be made clear. Here we 
discuss sex-related, temporal, linear and non-linear 
dose effects which are often involved in the estab-
lishment of chronic and endocrine diseases. 
We investigated three different GM corn namely 
NK 603, MON 810 and MON 863, which were fed to 
rats for 90 days. The raw data have been obtained by 
European governments and made publically avail-
able for scrutiny and counter-evaluation. These stud-
ies constitute a model to investigate possible sub-
chronic toxicological effects of these GM cereals in 
mammals and humans. These are the longest in vivo 
tests performed with mammals consuming these 
GMOs. The animals were monitored for numerous 
blood and organ parameters. One corn (NK 603) has 
been genetically engineered to tolerate the broad 
spectrum herbicide Roundup and thus contains resi-
dues of this formulation. The two other types of GM 
maize studied produce two different new insecticides 
namely modified versions of Cry1Ab (MON 810) and 
Cry3Bb1 (MON 863) Bacillus thuringiensis-derived 
proteins. Therefore, all these three GM maize contain 
novel pesticide residues that will be present in food 
and feed. As a result, the potential effects on physio-
logical parameters, due either to the recognized 
mutagenic effects of the GM transformation process 
or to the presence of the above mentioned novel pes-
ticides within these plants can be evaluated in animal 
feeding studies. 
2. Materials and Methods 
2.1. Experimental design 
The three animal feeding studies were con-
ducted in two different laboratories and at two dif-
ferent dates; at Monsanto (Missouri, USA) for NK 603 
and MON 810 (June 7, 2000) and at Covance Labora-
tories Inc. (Virginia, USA) for MON 863 (March 14, 
2001) on behalf of Monsanto. The young adult male 
and female rats, approximately 4-6 week-old, were of 
the Sprague-Dawley albino strain Crl:CD(SD)IGS 
BR®, (obtained from Charles River Laboratories Inc., 
NY, USA). The animals (400 per GMO; 200 for each 
sex) were randomized for similar body weight dis-
tribution. In fact, there were only two treated groups 
for each sex (20 animals each consuming specific GM 
maize feed). Only 10 rats were measured per group 
for blood and urine parameters and served as the ba-
sis for the major statistical analyses conducted. In ad-
dition, the investigators claimed that OECD guide-
lines and standards were followed. For each type of 
GM maize, only two feeding doses were tested per 
sex. This consisted of either 11 or 33% GM maize in 
an otherwise equivalent equilibrated diet; that is 
when the diet contained only 11% GM maize, the dif-
ference was made up by adding 22% non-GM maize 
(varieties not indicated). There were also two com-
parative control groups fed diets containing similar 
quantities of the closest isogenic or parental maize 
variety. Furthermore, groups of animals were also fed 
with diets containing one of six other normal 
(non-GM) reference maize lines; the same lines for the 
NK 603 and MON 810 tests, but different types for 
the MON 863 trials. We note that these unrelated, 
different non-GM maize types were not shown to be 
substantially equivalent to the GMOs. The quantity of 
some sugars, ions, salts, and pesticide residues, do in 
fact differ from line to line, for example in the 
non-GM reference groups. This not only introduced 
unnecessary sources of variability but also increased 
considerably the number of rats fed a normal 
non-GM diet (320) compared to the GM-fed groups 
(80) per transformation event, which considerably 
unbalances the experimental design. A group con-
sisting of the same number of animals fed a mixture 
of these test diets would have been a better and more 
appropriate control. In addition, no data is shown to 
demonstrate that the diets fed to the control and ref-
erence groups were indeed free of GM feed.   
2.2. Data collection 
The raw biochemical data, necessary to allow a 
statistical re-evaluation, should be made publically 
available according to European Union Directive 
CE/2001/18 but unfortunately this is not always the 
case in practice. On this occasion, the data we re-
quired for this analysis were obtained either through 
court actions (lost by Monsanto) to obtain the MON 
863 feeding study material (June 2005), or by courtesy 
of governments or Greenpeace lawyers. We thank the 
Swedish Board of Agriculture, May 30, 2006 for 
making public the NK 603 data upon request from 
Greenpeace Denmark and lawyers from Greenpeace 
Germany, November 8, 2006 for MON 810 material. 
This allowed us to conduct for the first time a precise 
and direct side-by-side comparison of these data from 
the three feeding trials with these GMOs.   
Approximately 80 different biochemical and 
weight parameters, including crude and relative 
measures (Table A, Annexes), were evaluated in se-
rum and urine after 5 and 14 weeks of feeding. We 
classified these per organ (markers by site of synthe-
sis or regulation). These organs weighed at the end of 
the experimental period, along with the whole body 
were: adrenal glands, brain, gonads, heart, kidneys, Int. J. Biol. Sci. 2009, 5 
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liver, and spleen. In addition, some parameters 
measured were related to bone marrow (blood cells) 
and pancreas (glucose) function. Unfortunately, some 
important measurements serving as markers for liver 
function were not conducted for technical or un-
known reasons. This included gamma glutamyl 
transferase after 90 days feeding, cholesterol and 
triglyceride levels in the NK 603 and MON 810 trials, 
and cytochrome P450 family members in all cases. In 
addition, important sex difference markers were also 
ignored such as blood sex or pituitary hormone lev-
els. Furthermore, it is well known and present in 
OECD guidelines that measurements should be con-
ducted for at least 3 different experimental points to 
study dose- or time-related effects. Contrastingly and 
for reasons that are not stated, in all three studies for 
all three GMOs, only 2 doses and periods of feeding 
were measured, which makes it difficult to evaluate 
d o s e  a n d  c u m u l a t i v e  e f f e c t s .  W e  h a v e  i n  a  f i r s t  i n -
stance indicated lacking values for different parame-
ters (Annexes, Tables B, C, D). 
2.3. Statistical power related to the experimen-
tal design 
The most fundamental point to bear in mind 
from the outset is that a sample size of 10 for bio-
chemical parameters measured two times in 90 days 
is largely insufficient to ensure an acceptable degree 
of power to the statistical analysis performed and 
presented by Monsanto. For example, concerning the 
statistical power in a t test at 5%, with the comparison 
of 2 samples of 10 rats, there is 44% chance to miss a 
significant effect of 1 standard deviation (SD; power 
56%). In this case to have a power of 80% would ne-
cessitate a sample size of 17 rats. Therefore, the statis-
tical power is insufficient in these studies to allow an 
a priori dismissal of all significant effects. Indeed, this 
is true overall with the amplitude of the effects that 
can usually be observed within three months, in the 
case of usual chronic toxicity appearing after one year 
of treatment. Hence, the lack of rejection of the null 
hypothesis at 5% does not mean that this hypothesis 
is true. Thus, the assessment of statistical power is 
absolutely necessary to understand the undetectable 
size effect; the statistical power depends on the sam-
ple and effect size, and the level of the test. This is 
exemplified when Monsanto performed one-way 
analysis of variance (ANOVA) calculations at 5% 
with a sample size of 10 animals for 10 groups. In this 
case the probability of not detecting a medium size 
effect [3] (0.5 SD for a t test for instance) is about 70% 
(power of the test 30%). However, the fact is that 
within 90 days, a chronic toxicity has a maximum 
chance of giving rise to a medium rather than large 
size effects. The disturbance of parameters at the be-
ginning of a disease is generally less important than 
at its end or as time progresses. Therefore, the proto-
col has to be drastically improved at this level, and as 
a result we consider that based on the analysis as 
presented by Monsanto that it fails to demonstrate 
that the consumption of these GM maize feeds was 
indeed safe as claimed. Any sign of toxicity should be 
taken into consideration to justify the prolongation of 
the experiment, or, if this is not possible, to reassess 
the statistical analysis, and to propose a scientifically 
valid physiological interpretation of any findings re-
lating to disturbed functional parameters on a per 
organ basis. This was the ultimate objective of this 
investigation. 
In reality, in their report containing the raw data 
and statistical analysis, Monsanto did not apply in 
any case their chosen and described statistical meth-
ods. Only parametric tests (one-way ANOVA under 
homoscedasticity hypothesis and Student t tests on 
contrasts) were employed. Moreover, to select sig-
nificant results, they only contrasted the data sets 
from the 33% GM maize feeding groups (for NK 603 
and MON 810) with all reference groups. Moreover, 
their biological interpretation of statistically signifi-
cant results differs from case to case. In particular, sex 
differences were frequently used to reject pathologi-
cal significance, despite the fact that this was without 
measuring effects on sex hormone levels. They also 
used the lack of linear dose-related effects, which is 
almost inevitable given that only two feeding doses 
were measured, to declare the diet as safe, as pro-
posed for MON 863 GM maize [4]. In the MON 863 
experiments, the authors still failed to apply their de-
clared methodology, which was slightly different. 
The ANOVA and contrast analysis (33% GM feeding 
dose versus controls) were in this case the determin-
ing criteria for evaluation of statistical significance, 
but only if the mean of the 33% GM feeding group 
was outside the range of the mean of the reference 
cohorts. All this increases noticeably the risks of false 
negative results.   
Consequently, based on the clear inadequacy of 
the statistical power used to refute toxic effects (for 
instance the unquestionable large size effects in this 
study), knowing also that billions of people and ani-
mals can consume these products prior to the per-
formance of appropriate in vivo safety evaluation, we 
applied an appropriate, experimentally validated sta-
tistical analytical methodology [5], elements of which 
are described below. 
2.4. Statistical methods employed  
We first repeated the same statistical analysis as Int. J. Biol. Sci. 2009, 5 
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conducted by Monsanto to verify descriptive statistics 
(sample size, means, and standard deviation) and 
ANOVA per sex, per variable and for each of the 
three GMO. For all that, the normality of the residues 
was tested using the Shapiro test and the homosce-
dasticity (homogeneity of the variances) using the 
Bartlett test. In the case where the Shapiro and Bart-
lett tests were non significant (*p > 0.05 and **p > 
0.01, respectively) we performed an ANOVA [6, 7], 
and in the case of heteroscedasticity the approximate 
Welch method was used. In the case where the 
Shapiro test was significant, we performed the 
Kruskal-Wallis rank sum test [7, 8]. 
We then analyzed the effects of the GM maize 
varieties on each sex and each diet by pairwise com-
parisons of the parameters o f  G M - f e d  r a t s  v e r s u s  
control groups, and subsequently to the unrelated 
non-GM maize reference groups. The statistical dif-
ferences between reference and control groups were 
calculated in order to study the effects of the different 
normal diets per se (due to differences in salts, sugars, 
minerals, vitamins, pesticides, etc composition), and 
indicated by contrast to Monsanto's work (see legend 
Table 1). In order to select the appropriate two-tailed 
comparison test [7], we again studied first normality 
(Shapiro test) and variance equality (F test). Accord-
ing to the results, we performed the adapted test; that 
is, an unpaired t test, a Welch corrected t test or a 
Mann-Whitney test (which is generally more appro-
priate with a sample size of 10). To perform multiple 
pairwise comparisons, we used the False Discovery 
Rate approach (FDR, [9]) to calculate adjusted 
p-values, in order to limit the rate of false positives to 
5%. We preferred Benjamini and Yekutieli's method 
[10] rather than that of Benjamini and Hochberg [11] 
as the parameters under investigation are not inde-
pendent. In addition, after centering and scaling the 
data, Principal Components Analysis (PCA, [12]) was 
performed in order to study the scattering of the dif-
ferent factors (sex, period, diet, dose and group). Fi-
nally, we established per group for each rat and by 
parameter the representations and paired tests cor-
responding to the temporal changes between the two 
feeding periods. 
We used the R language [7] version 2.5 for all 
statistical computations [13] with the appropriate 
package: pwr package for power studies, the bio-
conductor's multtest package for FDR [14-15] and the 
ADE4 package [16, 17] for multivariate analysis. 
3. Results 
We have previously reported indications of tox-
icity in rats fed with MON 863 GM maize for 90 days 
[5]. However, these signs of toxicity alone do not 
constitute proof of adverse health effects. We have 
therefore extended our initial analysis on the MON 
863 feeding data by collectively compiling the sig-
nificant differences observed in the physiological and 
biochemical parameters measured in feeding trials of 
rats with each of the three GM maize varieties MON 
863, MON 810 and NK 603 (Tables 1, 2; Annex Table 
E). When we then initially compare all p-values in 
our calculations with those of Monsanto (significant 
and non significant differences, Annex Table E), we 
obtain ratios of 432/452 (NK 603), 435/450 (MON 
810) and 442/470 (MON 863). By employing our sta-
tistical methods even if we reached a concordance 
with Monsanto’s results (Annex Table E), the level of 
precision of the main effects and their interpretation 
are highly different. Therefore, we then progressed to 
consider only relative differences over 5% (Tables 1 
and 2). 
3.1. NK 603 
We first evaluated the results for the NK 603 
feeding trials. The observations shown in Table 1 
with relative differences versus controls reveal that of 
23 significantly different effects that are supposed to 
be due to this GM maize, 18 are in males (raw means 
with SEM; Annex Table F). The repartition of effects 
is thus sex-dependent. In addition, in general liver 
(Fig. 1) and kidney (Fig. 2) parameters in all rats are 
sex differentially expressed. This is evident not only 
in the experiments involving NK 603, independently 
of the treatment at week 14, but also at week 5 (data 
not shown), but similarly observed in the MON 810 
and MON 863 feeding tests (Annex Fig. A- Fig. D). 
Males are clearly more sensitive than female 
animals to show physiological disturbances when fed 
NK 603. This is not observed for all three GM maize 
varieties. Moreover, most effects appear to be 
dose-dependent since 83% of male effects emerge 
only at the 33% feeding level (15/18), the highest GM 
maize concentration in the diet (Table 1). The maxi-
mal mean differences are observed in male kidney 
parameters.  
Urine phosphorus, for instance, is importantly 
disturbed in a dose-dependent manner and at both 5 
and 14 week periods of feeding and hence reproduci-
ble over time. The significant effect at this level does 
not appear to be a false positive result (week 5, 33%, 
adjusted p<0.003 for FDR calculated according to 
Benjamini and Yekutieli), considering that all pa-
rameters were not independent. Comparable results 
were also obtained for relative lymphocyte and neu-
trophil differences (all for males, week 14, 33%, ad-
justed p<0.005).   Int. J. Biol. Sci. 2009, 5 
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Table 1. Differences between NK 603-fed rats and controls. Study of the GMO effects, which are indicated by mean 
differences (%) for each parameter with the corresponding control group per sex and per dose. The significant differences 
versus controls (*p < 0.05, **p < 0.01), for all the parameters measured in the subchronic feeding tests, are presented. The 
parameters were grouped by organs according to the sites of synthesis or classical indicators of dysfunction. They were 
indicated for all groups only if they showed at least for one sex or one diet a significant and relatively ± 5% difference to the 
mean. The animals were male (m) or female (f) young adult rats fed during 5 or 14 weeks with the GM maize NK 603 (11 or 
33% in the diet) and compared with controls fed with a ‘‘substantially equivalent’’ isogenic maize line. The parameters were 
measured for 10 rats, except for the organ weights (20 rats), obtained only at the end of the experiment. In single-boxed 
numbers, we indicate the statistical differences between GMO-fed rats and controls, which are not found between the mean 
of the six reference groups and controls. A difference between reference and control groups could indicate an effect of the 
diet per se. In double-boxed numbers, among the effects due to the GMO, are indicated the statistical differences between 
the GMO groups and the mean of the six reference groups (which have not even eaten a genetically linked variety of maize 
as the control and the GMO treated groups). (p): Differences for the indicated parameters are not significant by a non-
parametric test but by a parametric one; all other differences by both. “Lar Uni Cell” means percent of large unnucleated cell 
count. 
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Fig. 1. Principal Component Analysis for liver pa-
rameters of all rats in the NK 603 feeding trial. The 
scheme obtained for parameters at week 14 explains 
66.65% of the total data variability (inertia) expressed on 2 
axes (49.84% for factor 1; 16.81% for factor 2), scale d=2. 
This demonstrates the clear separation of parameters 
values according to sex. 
 
 
Fig. 2. Principal Component Analysis for kidney 
parameters of all rats in the NK 603 experiment. 
The scheme obtained for parameters at week 14 explains 
44.78% of the total data variability (inertia) expressed on 2 
axes (27.27% for factor 1; 17.51% for factor 2), scale d=2. 
This demonstrates the clear separation of parameters 
values according to sex. 
 
 
 
 
 
 
Among 18 GM maize-related effects versus con-
trols, 11 show that groups of reference and control 
animals are similar in these cases (Table 1, framed 
values). However 6 GM-linked effects are also sig-
nificant versus all reference groups (Table 1, double 
framed values). At week 5, these relative maximal 
effects concern a diminution of blood and increase of 
urine creatinine clearance, and then a diminution of 
blood urea nitrogen. This is not observed at week 14 
(Fig. 3a,b). Even so, the kidney parameters measured 
are clearly the most reactive in both sexes; 52% of 
significant effects are noticed at this level, but kidney 
parameters represent only 31% of those measured in 
total. We also observe that ion concentrations are en-
hanced in urine of male GM fed rats. Besides this, 
crude and relative liver weights are also affected at 
the end of the maximal (33%) GM maize feeding level 
as well as that of the heart which for corresponding 
parameters to a comparable extent, showed up to an 
11% weight increase. Variations in females are far less 
frequent (5/23), with no clear significant differences 
except for urine phosphorus (major relative differ-
ence versus controls) and blood potassium (versus all 
groups). 
 
3.2. MON 810 
Feeding of MON 810 resulted in 11/15 signifi-
cant effects in females (Table 2, crude means with 
SEM; Annex Table G), which again highlights 
sex-differential effects. The sex-dependency for the 
measured parameters in liver and kidney is observed 
for all rats (Annex Fig. A & Fig. B). The significant 
GM-maize linked effects are generally detected either 
after 14 weeks of consumption or at a high GM feed 
dose in the diet. Parameters affected relate to: blood 
cells, adrenal gland and kidney weights, an increase 
in blood urea nitrogen and higher spleen weight. Sig-
nificantly disturbed parameters in males are concen-
trated in liver function at the 33% GM-maize feeding 
level in the diet, with a slight diminution in general 
serum albumin production. All disturbances are 
<20% and p-values are significant but >1% (Table 2, 
starred values). However, p-values adjusted for FDR 
are not significant. 
 Int. J. Biol. Sci. 2009, 5 
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Table 2. Differences between MON 810-fed rats and controls. For details, see legend Table 1. 
 
 
3.3. MON 863 
We have already described our evaluation of the 
MON 863 rat feeding studies [5]. Sex-dependency is 
well marked in this case also for the spreading of all 
parameters in liver and kidney (Annex Fig. C & Fig. 
D). The 34 significant GM-linked effects are equally 
distributed among males (16) and females (18). This 
contrasts with what is observed with NK 603 and 
MON 810. Nevertheless, 9/16 (56%) of males show 
statistically significant differences in kidney com-
pared to 4/18 females. However, although kidney 
parameters represent only 37.5% of all measurements, 
these data show a male-specific effect in kidney func-
tion. This trend is somewhat opposite to what is seen 
in liver parameters where males showed significant 
effects in 5/16 cases whereas the rate is 9/18 in fe-
males. Male rats also appear more sensitive to kidney 
disturbances at the higher GM feeding dose (11 ef-
fects at 33% versus 5 at 11%).   
Additional statistically significant differences 
include (i) a serum glucose and triglyceride increase 
(up to 40%) in females versus controls, together with 
a higher liver (7%) and overall body (3.7%) weight, 
(ii) elevated creatinine, blood urea nitrogen and urine 
chloride excretion in females, but greater variation in 
male kidney function (creatinine, and in urine so-
dium, potassium and phosphorus), (iii) up to a sig-
nificant kidney weight decrease (7%) with a notice-
able chronic nephropathy in males [18], (iv) a de-
crease (3.3%) in male body weights and (v) some liver 
function differences in males (albumin, globulin, as in 
females, plus alanine aminotransferase), although 
none of the FDR-adjusted p-values are significant. 
F u r t h e r m o r e ,  w e  h a v e  a l s o  m e a s u r e d  i n  t h i s  
study for the first time the differences between 
time-related variations (at weeks 5 and 14) for this 
GM maize variety, at each feeding dose versus con-
trols. We have represented these variations for each 
rat for all parameters. Among these, the significant 
variations corresponding to disturbed parameters are 
illustrated (Figs. 4-7). Our analysis clearly shows that 
female rat triglyceride levels vary between 5 and 14 Int. J. Biol. Sci. 2009, 5 
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weeks of feeding (Fig. 4; p=0.025). Triglyceride levels 
increase over time within the GM maize feeding 
group and whilst decreasing in the case of controls. 
Again in females, the increase in creatinine caused by 
MON 863 is more evident with longer feeding peri-
ods at an 11% level (Fig. 5; p=0.022). Another signifi-
cant difference (p=0.011), which we observe is a re-
ciprocal variation in female urine chloride excretion 
(Fig. 6). In the males, only urine potassium decreases 
over time with the consumption of GM feed but in-
creases in controls (Fig. 7, p=0.011). 
In summary, the tendency for physiological 
disturbance is characteristic of almost all rats of all 
GM-fed treatment groups, and physio-pathological 
profiles differ according to dose or sex. 
 
 
 
Fig. 3. Kinetic plot for urine creatinine clearance in male rats fed NK 603. For each rat at 33% GM maize feed 
level (a) and controls (b) the lines represent the variations between week 5 and 14 for this parameter (ml/min/100 g body 
weight). The dotted thick line represents the means variation. 
 
 
 
Fig. 4. Kinetic plot for female rat triglyceride levels in the MON 863 feeding trial. For each rat at 11% GM maize 
feed level (a) and controls (b) the lines represent the variations between week 5 and 14 for this parameter (mg/dL). The 
dotted thick line represents the mean variation. 
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Fig. 5. Kinetic plot for creatinine levels in female rats fed MON 863. For each rat at 11% GM maize feeding level (a) 
and controls (b) the lines represent the variations between week 5 and 14 for this parameter (mg/dL). The dotted thick line 
represents the mean variation. 
 
 
 
 
 
 
Fig. 6. Kinetic plot for urine chloride excretion in female rats fed MON 863. For each rat at 33% GM feed level (a) 
and controls (b) the lines represent the variations between week 5 and 14 for this parameter (meq/time). The dotted thick 
line represents the mean variation. Int. J. Biol. Sci. 2009, 5 
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Fig. 7. Kinetic plot for urine potassium in male rats fed MON 863. For each rat at 11% GM maize level (a) and 
controls (b) the lines represent the variations between week 5 and 14 for this parameter (mmol/L). The dotted thick line 
represents the mean variation. 
 
4. Discussion 
If a “sign of toxicity” may only provoke a reac-
tion, pathology or a poisoning, a so-called “toxic ef-
fect” is without doubt deleterious on a short or a long 
term. Clearly, the statistically significant effects ob-
served here for all three GM maize varieties investi-
gated are signs of toxicity rather than proofs of toxic-
ity, and this is essentially for three reasons. Firstly, 
the feeding trials in each case have been conducted 
only once, and with only one mammalian species. 
The experiments clearly need to be repeated prefera-
bly with more than one species of animal. Secondly, 
the length of feeding was at most only three months, 
and thus only relatively acute and medium-term ef-
fects can be observed if any similar to what can be 
derived in a process such as carcinogenesis [19, 20] or 
after endocrine disruption in adults [21]. Proof of 
toxicity is hard to decide on the basis of these condi-
tions. Longer-term (up to 2 years) feeding experi-
ments are clearly justified and indeed necessary. This 
requirement is supported by the fact that cancer, 
nervous and immune system diseases, and even re-
productive disorders for examples can become ap-
parent only after one or two years of a given inter-
vention treatment under investigation, but they will 
not be evident in all cases after three months of ad-
ministration when first signs of toxicity may be ob-
served [22, 23]. In addition, large effects (e.g. 40% in-
crease in triglycerides) in all likelihood will be missed 
with the protocol of the current studies, since they are 
limited by the number of animals used in each feed-
ing group and by the nature of the parameters stud-
ied. Thirdly, the statistical power of the tests con-
ducted is low (30%) because the experimental design 
of Monsanto (see Materials and Methods). However, 
it is important to note that these short-term (3-month) 
rat feeding trials are the only tests conducted on the 
basis of which regulators determine whether these 
GM crop/food varieties are as safe to eat as conven-
tional types. Given that these GM crops are poten-
tially eaten by billions of people and animals 
world-wide, it is important to discuss whether the 
experimental design, the statistical analyses and in-
terpretations originally undertaken are appropriate 
and sufficient.   
Any differences observed in comparison with 
the isogenic variety, has to be taken into account as a 
potential physiological disruption. This is particularly 
valid since any statistically differences that are ob-
served are highly unlikely to be arising from popula-
tion variation as in the case of humans due to the ge-
netic homogeneity of the rat strain used in these 
studies. Moreover, the standardized conditions of rat 
maintenance employed, which are stated to be in ac-
cordance with OECD standards [24, 25], make the 
diet the only factor of variation in the protocol. Thus, 
the GM maize component of the test diet is the major 
factor of difference if one directly compares treated 
rats and controls. This is indicated by stars in the Ta-
bles expressing the total characteristics of GM-linked 
physio-pathological profiles. The other results that 
are encompassed by frames in the Tables highlight 
that effects from the GM maize are over and above 
those observed for any of the six different diets; for 
instance, over that observed with a diet richer in salt Int. J. Biol. Sci. 2009, 5 
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or sugar over the 3-month feeding period. These ad-
ditional “control” diets could have been avoided with 
an experimental design that truly focused on the 
general question of GM toxicity.   
The first observation that we were able to make 
was that there is a good general concordance between 
our data and the results of Monsanto as presented in 
their original confidential reports, in particular on the 
proportion of statistically significant observations. 
However, the methodology we employed revealed 
different effects, which completely changed the in-
terpretation of the experimental results. For instance, 
the sex differences are fully taken into account in our 
study, which contrasts with the first published com-
ments of these data [18, 26, 27]. We evaluated and 
took note of differences in the reaction of male and 
female rats to the GM maize test diets based on ac-
cepted and now classical knowledge of endocrinol-
ogy [28], embryology [29, 30], physiology [31, 32], 
enzymology or hepatology [33] demonstrating 
sex-specific physio-pathological effects. Indeed, our 
present results fully confirmed the sex-specific dis-
tribution of effects on kidney and liver parameters for 
all rats in all three studies analyzed here. An identical 
effect in both sexes would have been exceptional, like 
with strong or acute toxicity. This is obviously not the 
case here. In addition, we considered equally impor-
tant effects that were neither time nor dose related, 
even if we detailed these when observed in the re-
sults. The proof for a linear dose dependency, as re-
quested by Doull and coll. [4] to determine the sig-
nificance of effects, is impossible with only two feed-
ing points with no prior standardization. Further-
more, a metabolic reaction either physiological or 
pathological is not necessarily linear in its response 
[34, 35]. Again, this does not invalidate a description 
of effects appearing at the higher GM feed doses. 
Even if the significant differences are around 5% 
of all comparisons for each GM corn, we believe that 
they either constitute a very good possibility to rep-
resent signs of toxicity, or at the very least should be 
considered as sufficiently strong evidence to justify a 
repeat of the experiments incorporating longer feed-
ing times, for several reasons. Firstly, the arguments 
of Hammond and coll. [18, 26, 27] from Monsanto 
and Doull and co-workers [4] cannot demonstrate 
that the statistically significant GM-feed linked dif-
ferences are not physiologically relevant [2]. Sec-
ondly, very few GM-feed effects appear only at the 
low dose or after the shortest (5 week) feeding period; 
8.6% for NK 603, 6.6% for MON 810, 14.7% for MON 
863 (Tables 1, 2, and ref. [5]). Thirdly, the marked sex 
difference effects observed for the GM maize feeding 
groups, in several instances, are found for physio-
logical markers in all rats. Therefore, there is little 
probability that these effects were a random, chance 
occurrence. Fourthly, our stringent statistical tools 
allowed differentiation of GM-feed impacts from dif-
ferences arising from variation in the composition of 
other reference diet. This is the first time that such an 
analysis has been conducted. Fifthly, there is a lack of 
cancer, hormonal or hepatic functional marker meas-
urements (for example, oncogene expression, sex 
steroid hormone levels, cytochrome P450 levels), that 
could have provided explanatory insight into the re-
sults. The lack of availability of this type of data may 
be of benefit to those that doubt the current observa-
tions provide evidence of potential signs of toxicity. 
Sixthly, the physiological and biochemical parameters 
found to be disrupted in these feeding studies fre-
quently provide a coherent, GM-specific picture of 
events, which corresponds and is in support of the 
generally admitted concept held by industry and 
regulators that GM crops and food should be consid-
ered on a case by case basis. Seventhly, several dou-
ble-framed outcomes encompass all dietary effects 
only after the 3 month period of feeding. Last but not 
least, the most marked and most numerous effects are 
on organs involved in detoxification like the kidney 
and liver, usually reached after a diet-linked toxicity. 
For instance in the NK 603 study statistically 
significant strong urine ionic disturbances and kidney 
markers imply renal leakage. This includes creatinine 
(increased urinary clearance), together with its dimi-
nution in the blood, and the decrease in urea nitro-
gen. Blood creatinine reduction has in some cases 
been found to be associated with muscle problems. It 
is therefore perhaps of note that the heart, as a very 
representative muscle organ was affected in the GM 
feeding groups. The possibility of renal porosity as 
evidenced by these data may be due to the presence 
of residues of Roundup herbicide, that are present in 
GM crop varieties such as the NK 603 maize investi-
gated here. We have previously demonstrated that 
glyphosate-based herbicides such as Roundup are 
highly toxic at very low concentrations to human 
embryonic kidney cells [36], inducing a decrease in 
viability, noticeably via inhibition of mitochondrial 
succinate dehydrogenase.   
The deficiency in kidney function we highlight 
to be present in male rats is different between animals 
fed NK 603 and MON 863. The latter is characterized 
by an increase in plasma creatinine levels and reten-
tion of ions, which were associated with a chronic 
interstitial nephropathy, as originally admitted in the 
Monsanto MON 863 report and by Hammond and 
coll. [18]. However, this disturbance in kidney func-
tion was dismissed in their conclusions because the Int. J. Biol. Sci. 2009, 5 
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strain of rat used in the feeding studies is apparently 
sensitive to this type of pathology, especially during 
aging, which was not the case here. However, this 
reasoning was admitted by various regulatory au-
thorities (EFSA, CGB in France). These arguments 
again appear flawed as the rats were still relatively 
young, 5 months by the end of the experimental pe-
riod and therefore below the age when they might be 
expected to spontaneously develop kidney diseases. 
More importantly, these kidney effects are clearly 
MON 863-specific since they are not observed with all 
three GM maize varieties and the control groups, and 
therefore could not have arisen from an inherent ge-
netic predisposition of the strain of rat used, which in 
addition was the same in all cases. Overall, no kidney 
parameters in male animals are disrupted in the 
MON 810 feeding group, even though sensitivity to 
toxics appears in general to be greater in this sex [37, 
38]. An additional contributory factor to this distur-
bance in kidney function could arise from either 
novel unintended toxic effect caused by the inherent 
mutagenic effect of the GM technology, or possibly 
due to the new mutant forms of Bt toxin produced by 
MON 863, which is completely different from that 
engineered into MON 810. However, MON 810-fed 
females have a slight kidney weight enhancement, 
which may correspond with a mild hyperplasia usu-
ally seen in association with immune inflammatory 
processes. A re-evaluation of the histological slides 
from these animals would be of interest to test this 
hypothesis. Furthermore, analysis of some pertinent 
markers of kidney function such as arterial tension or 
angiotensin levels are lacking from these studies. This 
type of investigation including controls where ani-
mals are fed a normal diet spiked with the corre-
sponding purified Bt toxin, would allow a more ra-
tional and precise interpretation of the results. 
In the case of the MON 863 feeding trials, which 
have previously been discussed [5] and are at the 
center of a debate [2, 4], new results have been ob-
tained by the re-evaluation of the data with more 
powerful statistical methods as we present here. In 
female rats, there is a risk of becoming pre-occupied 
with the reactions already ascribed to the GM feeding 
group since several parameters indicate increases in 
circulating glucose and triglyceride levels, with liver 
function parameters disrupted together with a slight 
increase in total body weight [5]. This physiological 
state is indicative of a pre-diabetic profile. We dem-
onstrate here that in female animals triglycerides pro-
file, creatinine or urine chloride excretion are differ-
entially and specifically altered over time in com-
parison to control groups, depending on the GMO 
dose. All these disruptions and differences taken to-
gether could be interpreted as clear signs of toxicity. 
The effects found after only 5 weeks of feeding 
or at lower 11% feed dose, cannot be neglected sim-
ply on the basis that they are less frequently ob-
served. Compensation or recuperation could occur 
after tissues are harmed, as possibly observed in the 
case of mice fed a diet containing Roundup Ready 
GM soy [39]. Peak inflammatory processes may occur 
in damaged tissues, followed by a regeneration phase 
as observed after bacteria/viral infection or a chemi-
cal toxic insult [40, 41]. For instance, urine potassium 
decreases in male rats over time in the GM MON 863 
group at the 11% feed dose, which was not observed 
in all but one of the controls. This effect is specifically 
time-dependent and thus does not appear to be arte-
factual. This type of punctual regeneration may be 
part of a carcinogenic process, and clearly even if to-
tal recovery occurs, this should not be taken as a sign 
that the GM feed is safe. 
5. Conclusions 
Patho-physiological profiles are unique for each 
GM crop/food, underlining the necessity for a 
case-by-case evaluation of their safety, as is largely 
admitted and agreed by regulators. It is not possible 
to make comments concerning any general, similar 
subchronic toxic effect for all GM foods. However, in 
the three GM maize varieties that formed the basis of 
this investigation, new side effects linked to the con-
sumption of these cereals were revealed, which were 
sex- and often dose-dependent. Effects were mostly 
concentrated in kidney and liver function, the two 
major diet detoxification organs, but in detail differed 
with each GM type. In addition, some effects on 
heart, adrenal, spleen and blood cells were also fre-
quently noted. As there normally exists sex differ-
ences in liver and kidney metabolism, the highly sta-
tistically significant disturbances in the function of 
these organs, seen between male and female rats, 
cannot be dismissed as biologically insignificant as 
has been proposed by others [4]. We therefore con-
clude that our data strongly suggests that these GM 
maize varieties induce a state of hepatorenal toxicity. 
This can be due to the new pesticides (herbicide or 
insecticide) present specifically in each type of GM 
maize, although unintended metabolic effects due to 
the mutagenic properties of the GM transformation 
process cannot be excluded [42]. All three GM maize 
varieties contain a distinctly different pesticide resi-
due associated with their particular GM event (gly-
phosate and AMPA in NK 603, modified Cry1Ab in 
MON 810, modified Cry3Bb1 in MON 863). These 
substances have never before been an integral part of 
the human or animal diet and therefore their health Int. J. Biol. Sci. 2009, 5 
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consequences for those who consume them, espe-
cially over long time periods are currently unknown. 
Furthermore, any side effect linked to the GM event 
will be unique in each case as the site of transgene 
insertion and the spectrum of genome wide muta-
tions will differ between the three modified maize 
types. In conclusion, our data presented here strongly 
recommend that additional long-term (up to 2 years) 
animal feeding studies be performed in at least three 
species, preferably also multi-generational, to provide 
true scientifically valid data on the acute and chronic 
toxic effects of GM crops, feed and foods. Our analy-
sis highlights that the kidneys and liver as particu-
larly important on which to focus such research as 
there was a clear negative impact on the function of 
these organs in rats consuming GM maize varieties 
for just 90 days. 
Abbreviations 
GM: genetically modified; m: modified toxin by 
mutagenesis. 
Acknowledgments 
We thank Michael Antoniou for assistance and 
comments on the compilation of this manuscript. The 
support of the French Ministry of Research is grate-
fully acknowledged. 
Greenpeace contributed to the start of the inves-
tigations by funding first statistical analyses in 2006, 
the results were then processed further and evaluated 
independently by the authors.   
Conflict of Interests 
The authors declare that there is no conflict of 
interest. 
References 
1.  Konig A, Cockburn A, Crevel RWR, et al. Assessment of the 
safety of foods derived from genetically modified (GM) crops. 
Food Chem Toxicol. 2004; 42: 1047-88. 
2.  Séralini GE, Spiroux de Vendômois J, Cellier D, et al. How 
subchronic and chronic health effects can be neglected for 
GMOs, pesticides or chemicals. Int J Biol Sci. 2009; 5: 438-43. 
3.  Cohen J. Statistical power analysis for the behavioral sciences. 
Hillsdale, USA: Lawrence Erlbaum Associates Publisher; 1988. 
4.  Doull J, Gaylor D, Greim HA, et al. Report of an Expert Panel on 
the reanalysis by Séralini et al. (2007) of a 90-day study con-
ducted by Monsanto in support of the safety of a genetically 
modified corn variety (MON 863). Food Chem Toxicol. 2007; 45: 
2073-85. 
5.  Séralini GE, Cellier D, Spiroux de Vendômois J. New analysis of 
a rat feeding study with a genetically modified maize reveals 
signs of hepatorenal toxicity. Arch Environ Contam Toxicol. 
2007; 52: 596-602. 
6.  Chambers JM, Freeny A, Heidelberger RM. Analysis of vari-
ance; design experiments in statistical models. London, UK: 
Wadsworth & Brooks/Cole; 1992. 
7.  Crawley MJ. Statistics an introduction using R. London, UK: 
Wiley; 2005. 
8.  Hollander M, Wolfe DA. Nonparametric statistical inference. 
In: John Wiley & sons, ed., New York; 1973: 115-20. 
9.  Shaffer JP. Multiple hypothesis testing. Annu Rev Psychol. 
1995; 46:561-84. 
10.  Benjamini Y, Yekutieli D. The control of the false discovery rate 
in multiple hypothesis testing under dependency. The Annals 
of Statistics. 2001; 29:1165-88. 
11.  Benjamini Y, Hochberg Y. Controlling the false discovery rate: a 
practical and powerful approach to multiple testing. JRSSB. 
1995; 57:289-300. 
12.  Hotelling H. Analysis of a complex of statistical variables into 
principal components. J Educ Psychol. 1933; 24: 417-41. 
13.  [Internet] Comprehensive R Archive Network, CRAN. 
http://cran.r-project.org 
14.  [Internet] Gentleman RC, Carey VJ, Huber W, et al. Bioinfor-
matics and Computational Biology Solutions Using R and Bio-
conductor; Series: Statistics for Biology and Health. 2005. 
http://www.springer.com/series/2848 
15.  [Internet] Katherine S, et al. 2004. http://bioconductor.org 
16.  Thioulouse J, Chessel D, Dolédec S, et al. ADE-4: a multivariate 
analysis and graphical display software. Statistics and Com-
puting 1996; 7: 75-83. 
17.  Chessel D, Dufour AB, Thioulouse J. The ade4 package-I- 
One-table methods. R News. 2004; 4: 5-10. 
18.  Hammond B, Lemen J, Dudek R, et al. Results of a 90-day safety 
assurance study with rats fed grain from corn root-
worm-protected corn. Food Chem Toxicol. 2006; 44: 147-60. 
19.  Farber E. Cancer development and its natural history a cancer 
prevention perspective. Cancer 1988; 62: 1676-79. 
20.  Chakraborty T, Chatterjee A, Rana A, et al. Carcinogen-induced 
early molecular events and its implication in the initiation of 
chemical hepatocarcinogenesis in rats: Chemopreventive role of 
vanadium on this process. Biochim Biophys Acta 2007; 1772: 
48-59. 
21.  Vos JG, Dybing E, Greim H A, et al. Health effects of endo-
crine-disrupting chemicals on wildlife, with special reference to 
the European situation. Crit Rev Toxicol. 2000; 30: 71-133. 
22.  Clarke J, Hurst C, Martin P, et al. Duration of chronic toxicity 
studies for biotechnology-derived pharmaceuticals: Is 6 months 
still appropriate. Regul Tox Pharmacol. 2008; 50: 2-22. 
23.  EFSA GMO Panel. Safety and nutritional assessment of GM 
plants and derived food and feed: the role of animal feeding 
trials. Food Chem Toxicol. 2008; 46 (Suppl 1): S2-70. 
24.  [Internet] OECD: Safety evaluation of foods derived by modern 
biotechnology: Concepts and principles; Paris, France: 1993. 
http://www.oecd.org 
25.  [Internet] OECD: Report of the workshop on the toxicological 
and nutritional testing of novel foods. SG/ICGB(98)1.1997. 
http://www.oecd.org 
26.  Hammond B, Dudek R, Lemen J, et al. Results of a 13 week 
safety assurance study with rats fed grain from glyphosate tol-
erant corn. Food Chem Toxicol. 2004; 42: 1003-14. 
27.  Hammond BG, Dudek R, Lemen JK, et al. Results of a 90-day 
safety assurance study with rats fed grain from corn 
borer-protected corn. Food Chem Toxicol. 2006; 44: 1092-9. 
28.  Reinisch JM, Ziemba-Davis M, Sanders SA. Hormonal contri-
butions to sexually dimorphic behavioral development in hu-
mans. Psychoneuroendocrinology. 1991; 16: 213-78. 
29.  Agras K, Willingham E, Shiroyanagi Y, et al. Estrogen recep-
tor-alpha and beta are differentially distributed, expressed and 
activated in the fetal genital tubercle. J Urol. 2007; 177: 2386-92. 
30.  Grimm VE, Frieder B. Differential vulnerability of male and 
female rats to the timing of various perinatal insults. Int J 
Neurosci. 1985; 27: 155-64. Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
719
31.  Toufexis D. Region- and sex-specific modulation of anxiety 
behaviours in the rat. J Neuroendocrinol. 2007; 19: 461-73. 
32.  Weinberg J, Sliwowska JH, Lan N, et al. Prenatal alcohol ex-
posure: foetal programming, the hypotha-
lamic-pituitary-adrenal axis and sex differences in outcome. J 
Neuroendocrinol. 2008; 20: 470-88. 
33.  Lupp A, Hugenschmidt S, Rost M, et al. Influence of recipient 
gender on intrasplenic fetal liver tissue transplants in rats: cy-
tochrome P450-mediated monooxygenase functions. Toxicol-
ogy. 2004; 197: 199-212. 
34.  Goldsmith JR, Kordysh E. Why dose-response relationships are 
often non-linear and some consequences. J Expo Anal Environ 
Epidemiol. 1993; 3: 259-76. 
35.  Calabrese EJ, Baldwin LA. Hormesis: U-shaped dose responses 
and their centrality in toxicology. Trends Pharmacol Sci. 2001; 
22: 285-91. 
36.  Benachour N, Sipahutar H, Moslemi S, et al. Time- and 
dose-dependent effects of roundup on human embryonic and 
placental cells. Arch Environ Contam Toxicol. 2007; 53: 126-33. 
37.  Iliescu R, Yanes LL, Bell W, et al. Role of the renal nerves in 
blood pressure in male and female SHR. Am J Physiol Regul 
Integr Comp Physiol. 2006; 290: R341-44. 
38.  Attia DM, Goldschmeding R, Attia MA, et al. Male gender 
increases sensitivity to renal injury in response to cholesterol 
loading. Am J Physiol Renal Physiol. 2003; 284: F718-26. 
39.  Malatesta M, Baldelli B, Battistelli S, et al. Reversibility of 
hepatocyte nuclear modifications in mice fed on genetically 
modified soybean. Eur J Histochem. 2005; 49: 237-42. 
40.  Mehendale HM. Mechanism of the lethal interaction of chlor-
decone and CCl4 at non-toxic doses. Toxicol Lett. 1989; 49: 
215-41. 
41.  Pickart L. The human tri-peptide GHK and tissue remodeling. J 
Biomater Sci Polym Ed. 2008; 19: 969-88. 
42.  Latham JR, Wilson AK, Steinbrecher RA. The Mutational Con-
sequences of Plant Transformation. J Biomed Biotech. 2006; 
25376: 1-7. 
 
 
Authors Biographies 
Prof. Gilles-Eric Séralini is a molecular biologist at the University of Caen, team leader and author of 
books on environment and GMOs. He was expert for the French government (1998-2007) and the European 
Union at the WTO level and for the council of Ministers on GMOs (2003, 2008), president of the scientific coun-
cil for independent research on genetic engineering (CRIIGEN), and receiver of Order of Merit for his scientific 
career (2008). Correspondence: criigen@unicaen.fr   
Dr. Joël Spiroux de Vendômois is doctor in medicine, specialist in environmental pathologies and 
co-organizer of the first European meeting on environmental pathologies. 
François ROULLIER is a statistician. 
Dr. Dominique CELLIER is a researcher in bioinformatics, co-organizer of a Master 2 in bioinformatics 
and statistics at the University of Rouen. 
 Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
720
ANNEXES 
Table A. Parameters as measured by Monsanto in subchronic toxicological studies in rats, sorted by or-
gans. * data available only for MON 863; ** raw data not analyzed by Monsanto for MON863; # data available only for NK 
603 and MON 810; ## raw data lacking in the original NK 603 and MON 810 reports from Monsanto, ? non understandable 
lack of data. 
Parameters (total 83)  Units  Weeks  Abbreviations 
Body Weight (Wt)  g  14  TBWEIGHT 
Adrenal (3)          
Adrenal Wt  g  14  ADRENAL 
Adrenal % Body Wt  %  14  ADRENAL_%Body 
Adrenal % Brain Wt  %  14  ADRENAL_%Brain 
Brain (2)          
Brain Wt  g  14  BRAIN 
Brain % Body Wt  %  14  BRAIN_%Body 
Bone marrow (22)          
White Blood Cell  x10E3/ µL  5, 14  WBC 
Platelet Count  x10E3/ µL  5, 14  PLT 
Absolute Neutrophils  x10E3/ µL  5, 14  ABS_NEUT 
Absolute Lymphocytes  x10E3/ µL  5, 14  ABS_LYMPH 
Absolute Monocytes  x10E3/ µL  5, 14  ABS_MONO 
Absolute Eosinophils  x10E3 /µL  5, 14  ABS_EOS 
Absolute Basophils   x10E3/ µL  5, 14  ABS_BASO 
Absolute Lar Uni Cell #  x10E3/ µL  5, 14  ABS_LUC 
Neutrophils **  %  5, 14  NEUT 
Lymphocytes **  %  5, 14  LYMPH 
Monocytes **  %  5, 14  MONO 
Eosinophils **  %  5, 14  EOS 
Basophils **  %  5, 14  BASO 
Lar Uni cell #  %  5, 14  LUC 
Red Blood Cell  x10E6 µL  5, 14  RBC 
Hemoglobin Conc.  g/dL  5, 14  HGB 
Hematocrit %  5,  14  HCT 
Mean Corpuscular Vol.  fL  5, 14  MCV 
Mean Corpuscular Hgb  pg  5, 14  MCH 
Mean Corpuscular Hgb Conc.  g/dL  5, 14  MCHC 
Absolute Reticulocyte Count *  x10E3/ µL  5, 14  ABS_RETIC 
Reticulocyte Count *  %RBC  5, 14  RETIC 
Liver (17)      
Liver Wt  g  14  LIVER 
Liver % Body Wt  %  14  LIVER_%Body 
Liver % Brain Wt  %  14  LIVER_%Brain 
Albumin g/dL  5,  14  ALBUMIN 
Globulin g/dL  5,  14  GLOBULIN 
Albumin/Globulin Ratio  -  5, 14  A/G_RATIO 
Alanine Aminotransferase  U/L  5, 14  SGPT_ALT 
Aspartate Aminotransferase  U/L  5, 14  SGOT_AST 
Alkaline Phosphatase /AMP  U/L  5, 14  ALKPHOS 
Total Protein  g/dL  5, 14  TOT_PROTEIN 
Gamma Glutamyl Transferase  U/L  5, ?  GAMMA_GT 
Total Bilirubin  mg/dL  5, 14  TOT_BILI 
Direct Bilirubin  mg/dL  5, 14  DIR_BILI 
Cholesterol *  mg/dL  5, 14  CHOLEST 
Triglycerides *  mg/dL  5, 14  TRIGLY Int. J. Biol. Sci. 2009, 5 
 
http://www.biolsci.org 
721
Parameters (total 83)  Units  Weeks  Abbreviations 
Individual Prothrombin Time  seconds  14  PT 
Activated Partial  
Thromboplastin Time 
seconds 14  APTT 
Heart (3)          
Heart Wt  g  14  HEART 
Heart % Body Wt  %  14  HEART_%Body 
Heart % Brain Wt  %  14  HEART_%Brain 
Kidney (25)          
Kidney Wt  g  14  KIDNEY 
Kidney % Body Wt  %  14  KIDNEY_%Body 
Kidney % Brain Wt  %  14  KIDNEY_%Brain 
Urine Calcium  mg/dL  5, 14  U_CALCIUM 
Urine Creatinine  mg/dL  5, 14  U_CREAT 
Urine Protein  mg/dL  5, 14  U_PROTEIN 
Urine Phosphorus  mg/dL  5, 14  U_PHOS 
Urine Sodium  mmol/L  5, 14  U_SODIUM 
Urine Potassium  mmol/L  5, 14  U_POTASSIUM 
Urine Chloride  mmol/L  5, 14  U_CHLORIDE 
Urine Creatinine Clearance #  mL/min/100 g body wt  5, 14  U_CREAT_Clear 
Urine Sodium Excretion *  meq/time  5, 14  U_SOD_excr 
Urine Potassium Excretion *  meq/time  5, 14  U_POT_excr 
Urine Chloride Excretion *  meq/time  5, 14  U_CHLOR_excr 
Total Urine Volume  mL/ collection period  5, 14  U_TOTALVOL 
NA/K Ratio  -  5, 14  U_NA/K_RATIO 
Blood Urea Nitrogen  mg/dL  5, 14  BUN 
Calcium mg/dL  5,  14  CALCIUM 
Creatinine mg/dL  5,  14  CREAT 
Phosphorus mg/dL  5,  14  PHOS 
Sodium mmol/L  5,  14  SODIUM 
Potassium mmol/L  5,  14  POTASSIUM 
Chloride mmol/L  5,  14  CHLORIDE 
PH ##  U PH  5, 14  U_PH 
Specific Gravity ##  U SG  5, 14  U_SG 
Pancreas (1)          
Glucose mg/dL  5,  14  GLUCOSE 
Gonads (6)          
Testis Wt  g  14  TESTIS 
Testis % Body Wt  %  14  TESTIS_%Body 
Testis % Brain Wt  %  14  TESTIS_%Brain 
Ovary Wt  g  14  OVARY 
Ovary % Body Wt  %  14  OVARY_%Body 
Ovary % Brain Wt  %  14  OVARY_%Brain 
Spleen (3)          
Spleen Wt  g  14  SPLEEN 
Spleen % Body Wt  %  14  SPLEEN_%Body 
Spleen % Brain Wt  %  14  SPLEEN_%Brain 
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Table B. Values lacking in the NK603 subchronic toxicological feeding studies in rats. Except for two deceased 
rats (*) for which organs were not weighed nor biochemical parameters measured, the data lacking were generally unex-
plained by Monsanto. The number of the group of 20 rats each is indicated first, followed by two dots and the treatment 
(GMO, or isogenic line as control Ctrl, and unrelated reference group number among the 6 used as refX), as well as the sex, 
male (m) or female (f). 
Parameter  Group  Sex  Week  Dose (%)  Rat number 
1:GMO m  5  11  14 
5: ref1  m  5  33  18 
7: ref3  m  5  33  2 
1:GMO m  14 11  18 
4: Ctrl  m  14  33  1 
7: ref3  m  14  33  6 
10:ref6 m  14  33  16 
7: ref3  f  5  33  1 
1:GMO f  14 11  2 
1:GMO f  14 11  6 
3: Ctrl  f  14  11  14 
4: Ctrl  f  14  33  6 
4: Ctrl  f  14  33  16 
5: ref1  f  14  33  11 
5: ref1  f  14  33  14 
5: ref2  f  14  33  6 
5: ref3  f  14  33  17 
5: ref3  f  14  33  18 
5: ref4  f  14  33  16 
Urine 
5: ref5  f  14  33  18 
              
4: Ctrl  m  14  33  14 
6: ref2  f  5  33  14 
8: ref4  f  5  33  11 
9: ref5  f  5  33  11 
2:GMO f  14 33  1 
Hematology 
4: Ctrl  f  14  33  17 
          
2:GMO m  14 33  13*  Organ weights 
6: ref2  m  14  33  9* 
 
 
Table C. Values lacking in MON 810 subchronic toxicological feeding studies in rats. Except for one deceased 
rat (*) for which organs are not weighted nor biochemical parameters measured, the data lacking were generally unexplained 
by Monsanto. See legend Table B. 
Parameter  Group  Sex  Week  Dose (%)  Rat number 
5: ref1  m  5  33  18 
7: ref3  m  5  33  2 
3: Ctrl  m  14  11  8 
7: ref3  m  14  33  6 
10:ref6 m  14  33  16 
1:GMO f  5  11  9 
3: Ctrl  f  5  11  18 
7: ref3  f  5  33  1 
3: Ctrl  f  14  11  2 
3: Ctrl  f  14  11  18 
5: ref1  f  14  33  2 
5: ref1  f  14  33  11 
5: ref1  f  14  33  14 
6: ref2  f  14  33  6 
7: ref3  f  14  33  17 
7: ref3  f  14  33  18 
Urine 
8: ref4  f  14  33  16 Int. J. Biol. Sci. 2009, 5 
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9: ref5  f  14  33  18 
          
1: GMO  m  5  11  3 
2: GMO  m  5  33  3 
6: ref2  f  14  33  14 
8: ref4  f  14  33  11 
Hematology 
9: ref5  f  14  33  11 
          
Organ weights  6: ref2  m  14  33  9* 
 
 
 
Table D. Values lacking in MON 863 subchronic toxicological feeding studies in rats. See legend Table B. 
Parameter  Group  Sex  Week  Dose (%)  Rat number 
2 :GMO  m  14  33  B38667 
5 : ref1  m  14  33  B38685 
8 : ref4  m  14  33  B38743 
5 : ref1  f  14  33  B38884 
5 : ref1  f  14  33  B38890 
6 : ref2  f  14  33  B38907 
6 : ref2  f  14  33  B38911 
7 : ref3  f  14  33  B38923 
7 : ref3  f  14  33  B38925 
9 : ref5  f  14  33  B38962 
9 : ref5  f  14  33  B38965 
9 : ref5  f  14  33  B38967 
Urine 
10 :ref6  f  14  33  B38989 
          
8 : ref4  m  14  33  B38749 
2 :GMO   m  14  33  B38667 
6 : ref1  m  14  33  B38711 
10 :ref6  m  14  33  B38788 
2 :GMO  m  14  33  B38667 
3 : ctrl  f  14  11  B38809 
1 :GMO  f  14  11  B38845 
7 : ref3  f  14  33  B38923 
Hematology 
9 : ref5  f  14  33  B38967 
                
2 :GMO  m  14  33  B38667 
7 : ref3  f  14  33  B38923 
Organ weights 
9 : ref5  f  14  33  B38967 
 
 
Table E. Concordances between Monsanto (M) and present CRIIGEN (C) statistical analysis. The total sig-
nificant (signif.) and non significant (non signif.) effects measured by p values for each GM corn treatment are detailed. 
M  C  Signif.  non  signif.  total 
NK 603 
signif. 24  5  29 
non signif.  15  408  423 
total  39  413  452 
MON 810 
signif. 15  4  19 
non signif.  11  420  431 
total  26  424  450 
MON 863 
signif.  23  15  38 
non signif.  13  419  432 
total  36  434  470 
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Table F. NK 603: Effects of GM feed treatment classified by organ type. Based on Table 1, all the parameters 
statistically significant different between GM corn fed rats and corresponding controls are represented by their crude means 
± SEM in exact corresponding units. The differences were always p < 0.05 or < 0.01 compared to controls according to one 
or two asterisks in Table 1. The symbol (p) means that the difference is significant only in a parametric test. The controls are 
submitted to substantially equivalent isogenic maize with the same diet composition, with all usual conditions exactly 
identical (genetic, temperature, light, space of caging, water and others). The time of exposure (weeks 5 and 14 corre-
sponding, respectively, to 4 and 13 weeks of GMO diet), the sexes (males: m, females: f), and the dose (11 or 33% of GM 
maize in the equilibrated diet) are indicated. 
Control GMO  Parameters Unit  Week    Sex  Dose  (%) 
mean ± sem  mean ± sem 
            
BONE MARROW                   
Abs. lymphocytes  µL (X10E3)  14  f  33  6.01 ± 0.62  4.65 ± 0.24 
Neutrophils  µL (X10E3)  14  m  33  17.51 ± 0.7  11.60 ± 0.89 
Lymphocytes  %  14  m  33  74.41 ± 0.58  80.53 ± 1.06 
Eosinophils (p)  %  5  m  11  1 ± 0.11  1.38 ± 0.11 
Lar uni cell  %  5  f  11  1.23 ± 0.09  1.64 ± 0.11 
               
HEART              
Heart Wt  g  14  m  33  1.78 ± 0.04  1.98 ± 0.06 
Heart % Body Wt  %  14  m  33  0.33 ± 0.01  0.36 ± 0.01 
Heart % Brain Wt  %  14  m  33  80.18 ± 2.18  87.22 ± 2.47 
               
KIDNEY              
Urine Phosphorus  mg/dL  5  m  33  110.73 ± 8.66  185.38 ± 11.13 
Urine Phosphorus  mg/dL  5  f  33  182.35 ± 15.4  254.08 ± 23.65 
Urine Phosphorus  mg/dL  14  m  33  88.69 ± 19.86  174.77 ± 9.75 
Urine sodium (p)  mmol/L  14  m  33  30 ± 4.11  43.2 ± 4.33 
Urine potassium  mmol/L  14  m  33  166.72 ± 22.95  223.90 ± 12.02 
Urine creat. clearance  mL/min/100 g/bw  5  m  33  0.59 ± 0.05  0.84 ± 0.06 
Blood urea nitrogen  mg/dL  5  m  11  14.02 ± 0.61  12.10 ± 0.29 
Blood urea nitrogen  mg/dL  5  m  33  14.84 ± 0.75  12.93 ± 0.47 
Creatinine  mg/dL  5  m  11  0.32 ± 0.02  0.24 ± 0.02 
Creatinine  mg/dL  5  m  33  0.31 ± 0.01  0.24 ± 0.02 
Phosphorus  mg/dL  5  m  33  8.02 ± 0.15  7.48 ± 0.17 
Potassium  mmol/L  14  f  33  7.30 ± 0.15  8.22 ± 0.19 
               
LIVER              
Liver Wt  g  14  m  33  14.86 ± 0.32  16.34 ± 0.61 
Liver % Body Wt  %  14  m  33  2.82 ± 0.04  2.96 ± 0.04 
Alkaline phosphatase  U/L  14  f  11  41.10 ± 2.44  53 ± 4.014 
 
 
 
 
Table G. MON 810: Effects of GMO treatment classified by organs, based on Table 2. See legend Table F. 
Control GMO  Parameters Unit  Week    Sex  Dose  (%)
mean ± sem  mean ± sem 
            
ADRENAL           
Adrenal Wt  g  14  f  11  0.07 ± 0.01  0.08 ± 0.01 
Adrenal % Brain Wt  %  14  f  11  3.42 ± 0.11  3.89 ± 0.16 
              
BONE MARROW           
White Blood Cell Count  µL (X10E3 )  5  f  33  9.83 ± 1.34  8.16 ± 1.58 
Absolute lymphocytes  µL (X10E3 )  5  f  33  8.57 ± 1.17  7.11 ± 1.39 
Basophils  %  14  f  33  0.79 ± 0.1  0.68 ± 0.13 
Lar uni cell (p)  %  5  f  11  1.02 ± 0.32  1.39 ± 0.46 Int. J. Biol. Sci. 2009, 5 
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Control GMO  Parameters Unit  Week    Sex  Dose  (%)
mean ± sem  mean ± sem 
              
KIDNEY           
Kidney Wt (p)  g  14  f  11  2.23 ± 0.19  2.38 ± 0.25 
Kidney % Brain Wt (p)  %  14  f  11  109.76 ± 2.08  117.29 ± 2.84 
Blood urea nitrogen  mg/dL  5  f  33  15.02 ± 2  17.11 ± 1.91 
              
LIVER           
Albumin  g/dL  5  m  33  4.24 ± 0.14  3.97 ± 0.2 
Albumin  g/dL  14  m  33  4.44 ±0.16  4.15 ± 0.22 
albumin/globulin ratio  -  5  m  33  1.97 ± 0.27  1.77 ± 0.22 
albumin/globulin ratio  -  14  m  33  1.85 ± 0.18  1.66 ± 0.13 
              
SPLEEN           
Spleen Wt  g  14  f  11  0.54 ± 0.09  0.63 ± 0.24 
Spleen % Brain Wt  %  14  f  11  26.39 ± 0.86  31 ± 2.42 
 
 
 
 
 
 
 
Fig. A. Principal Component Analysis for liver pa-
rameters in all rats of the MON 810 experiment. 
The scheme obtained for parameters at week 14 explains 
62.48% of the total data variability (inertia) expressed on 2 
axes (47.46% for factor 1; 15.02% for factor 2), scale d=2. 
This demonstrates the clear separation of parameters 
values according to sex. 
 
 
Fig. B. Principal Component Analysis for kidney 
parameters in all rats of the MON 810 experiment. 
The scheme obtained for parameters at week 14 explains 
43.16% of the total data variability (inertia) expressed on 2 
axes (24.87% for factor 1; 18.29% for factor 2), scale d=2. 
This demonstrates the clear separation of parameters 
values according to sex. 
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Fig. C. Principal Component Analysis for liver pa-
rameters in all rats of the MON 863 experiment. 
The scheme obtained for parameters at week 14 explains 
42.42% of the total data variability (inertia) expressed on 2 
axes (32.01% for factor 1; 10.41% for factor 2), scale d=2. 
This demonstrates the clear separation of parameters 
values according to sex. 
 
Fig. D. Principal Component Analysis for kidney 
parameters in all rats of the MON 863 experiment. 
The scheme obtained for parameters at week 14 explains 
47.73% of the total data variability (inertia) expressed on 2 
axes (26.95% for factor 1; 20.78% for factor 2), scale d=5. 
This demonstrates the clear separation of parameters 
values according to sex. 